Canada Infectious Diagnostics Market Outlook to 2021

Published: August 2015
No. of Pages: 68
   

GlobalData''s new report, "Canada Infectious Diagnostics Market Outlook to 2021", provides key market data on the Canada Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Infectious Diagnostics market.
  • Global corporate-level profiles of key companies operating within the Canada Infectious Diagnostics market.
  • Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what''s the most preferred mode of product distribution - Identify, understand and capitalize.

Canada Infectious Diagnostics Market Outlook to 2021

Table of Contents

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5

2 Introduction 6
2.1 What Is This Report About? 6
2.2 Infectious Diagnostics Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7

3 Infectious Diagnostics Market, Canada 9
3.1 Infectious Diagnostics Market, Canada, Revenue ($m), 2007-2014 9
3.2 Infectious Diagnostics Market, Canada, Revenue ($m), 2014-2021 11
3.2.1 Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), by Segment, 2007-2014 13
3.2.2 Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), by Segment, 2014-2021 15
3.3 Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), 2013-2014 17
3.4 Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), 2014 18

4 Overview of Key Companies in Canada, Infectious Diagnostics Market 20
4.1 Qiagen N.V. 20
4.1.1 Company Overview 20
4.2 Abbott Laboratories 20
4.2.1 Company Overview 20
4.3 Hologic, Inc. 20
4.3.1 Company Overview 20
4.4 F. Hoffmann-La Roche Ltd. 21
4.4.1 Company Overview 21
4.5 Becton, Dickinson and Company 21
4.5.1 Company Overview 21
4.6 Siemens Healthcare 21
4.6.1 Company Overview 21
4.7 bioMerieux S.A. 22
4.7.1 Company Overview 22
4.8 Alere Inc. 22
4.8.1 Company Overview 22
4.9 Bio-Rad Laboratories, Inc. 22
4.9.1 Company Overview 22

5 Infectious Diagnostics Market Pipeline Products 23

6 Financial Deals Landscape 34
6.1 Debt Offerings 34
6.1.1 SQI Diagnostics Completes Second and Final Tranche of Private Placement of Debentures for USD1.3 Million 34
6.2 Equity Offerings 35
6.2.1 SQI Diagnostics Raises USD2.2 Million In in First Tranche of Private Placement of Shares 35
6.2.2 Spectral Diagnostics Raises USD4.7 Million in Second Tranche of Private Placement of Shares 36
6.3 Partnerships 38
6.3.1 Vivione Biosciences Enters into Distribution Agreement with Trillium Diagnostics 38
6.3.2 PAML Enters into Co-Development Agreement with Axela 39
6.3.3 Biocartis Enters into Licensing and Development Agreement with Microbiome 40
6.4 Venture Financing 41
6.4.1 Fio Raises USD0.7 Million in Venture Financing 41

7 Recent Developments 42
7.1 Corporate Communications 42
7.1.1 Jun 22, 2015: InVivo Therapeutics Receives Notice of Allowance on Patent Covering Broader Compositions for Neuro-Spinal Scaffold and Neuro-Spinal Scaffold Plus Stem Cells 42
7.1.2 Jun 18, 2015: Dutch hospital acquires 1,000th Agility, Elekta’s radiotherapy beam-shaping technology for treating cancer 43
7.1.3 Jun 17, 2015: Newly FDA-Approved Device for Stroke Prevention Available at Mercy 44
7.1.4 Mar 03, 2015: SQI Diagnostics Appoints Chief Financial Officer 45
7.1.5 Nov 04, 2014: MedMira Names Robyn Cook As Chief Corporate Officer 45
7.1.6 Oct 02, 2014: 3-V Biosciences To Present Clinical And Preclinical Data For FASN Inhibitors At EORTC-NCI-AACR 2014 46
7.1.7 Sep 29, 2014: SQI Diagnostics Announces New Chairman of Board of Directors 47
7.1.8 Sep 24, 2014: Spectral announces board changes 47
7.1.9 Sep 17, 2014: SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States 48
7.2 Financial Announcements 48
7.2.1 Jun 17, 2015: Derma Sciences Announces Medicare Coverage Reinstated For MEDIHONEY Products with Reimbursable Codes by Centers for Medicare & Medicaid Services 48
7.2.2 May 21, 2015: SQI Diagnostics Reports Second Quarter Financial Results 49
7.2.3 May 13, 2015: Spectral Announces First Quarter 2015 Results 51
7.2.4 May 09, 2015: Shanghai MicroPort Orthopedics Hosts First SuperPath Online Symposium 51
7.2.5 Mar 25, 2015: Spectral Announces Fourth Quarter and Fiscal 2014 Results 52
7.2.6 Mar 20, 2015: MedMira Reports Second Quarter Financial Results 53
7.2.7 Feb 26, 2015: SQI Diagnostics Reports First Quarter Financial Results 53
7.2.8 Dec 31, 2014: MicroPort Completes First Implantation of Reewarm18 55
7.2.9 Dec 24, 2014: MedMira Reports First Quarter Results 56
7.2.10 Dec 17, 2014: SQI Diagnostics Reports Fourth Quarter and Fiscal 2014 Results 56
7.2.11 Nov 28, 2014: MedMira Reports 2014 Fourth Quarter And Year End Financial Results 58
7.2.12 Nov 24, 2014: Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA 59
7.2.13 Nov 13, 2014: Spectral Announces Third Quarter 2014 Results 60
7.2.14 Aug 13, 2014: Spectral Announces Second Quarter, 2014 Results 61
7.3 Other Significant Developments 62
7.3.1 Jan 28, 2015: Two of MedMira’s Multiplo Tests Procured for UNAIDS Program in Central Asia 62
7.3.2 Dec 16, 2014: Spectral Announces Effective Date of Name Change 62
7.3.3 Dec 15, 2014: SQI Diagnostics Wins Additional Business from UK-based Customer 63
7.4 Strategy And Business Planning 64
7.4.1 Jul 20, 2015: MedMira Opens US Subsidiary in Atlanta, GA 64

8 Appendix 65
8.1 Research Methodology 66
8.1.1 Coverage 66
8.1.2 Secondary Research 66
8.1.3 Primary Research 67
8.1.4 Company Share Analysis 67
8.1.5 Distribution Share Analysis 67
8.2 GlobalData Consulting 67
8.3 Contact Us 68
8.4 Disclaimer 68

List of Tables

Table 1: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 10
Table 2: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 12
Table 3: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 14
Table 4: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 16
Table 5: Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 17
Table 6: Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 19
Table 7: Infectious Diagnostics Market Pipeline Products 23
Table 8: SQI Diagnostics Completes Second and Final Tranche of Private Placement of Debentures for USD1.3 Million 34
Table 9: SQI Diagnostics Raises USD2.2 Million In in First Tranche of Private Placement of Shares 35
Table 10: Spectral Diagnostics Raises USD4.7 Million in Second Tranche of Private Placement of Shares 36
Table 11: Vivione Biosciences Enters into Distribution Agreement with Trillium Diagnostics 38
Table 12: PAML Enters into Co-Development Agreement with Axela 39
Table 13: Biocartis Enters into Licensing and Development Agreement with Microbiome 40
Table 14: Fio Raises USD0.7 Million in Venture Financing 41

List of Figures

Figure 1: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 9
Figure 2: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Figure 3: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 13
Figure 4: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 15
Figure 5: Infectious Diagnostics Market, Canada, Company Share (%) 2014 18

Published By: GlobalData
Product Code: GlobalData32849


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we´┐Żll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: